wart. common wart
Conditions
Interventions
Intervention 1: Use of 1.1000 purified candida antigen solution (Greer, USA) intralesionally into greatest wart lesions every 3 weeks for 3 doses in intervention group. Intervention 2: Use of cryother
Treatment - Drugs
Use of 1.1000 purified candida antigen solution (Greer, USA) intralesionally into greatest wart lesions every 3 weeks for 3 doses in intervention group.
Use of cryotherapy with liquid nitrogen weekly for 10 weeks in control group.
Sponsors
Vice chancellor for research of Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients older than 15 years that have verucca vulgaris and plantar warts whom referred to dermatology clinic of Quaem hospital; no prior allergic response to mumps or Candida antisera; not be pregnant or lactating; no primary or iatrogenic immuno-supression; no infection with human immunodeficiency virus type 1( HIV1); no hypersensitivity to lidocaine; no previous treatment for wart during 1 month ago Exclusion criteria:Taking any treatment for wart during study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lesion improvement rate. Timepoint: Weekly for cryotherapy until 10 weeks, every 3 weeks for Candida antigen until three doses. Method of measurement: Measuring the size of two largest perpendicular diameter of lesion in millimeter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: Weekly for cryotherapy group and each 3 weeks for candida antigen group. Method of measurement: Clinical evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Pouran Layegh
Mashhad University of Medical Sciences
Outcome results
None listed